Abstract
Despite aggressive surgical treatment, rational antibiotic therapy, and modern intensive care, generalised peritonitis remains a major threat in the paediatric age group. Several adjuvant strategies such as peritoneal saline lavage and peritoneal drainage have been utilised. Taurolidine, derived from the amino acid taurine, has bactericidic, antiendotoxic, and antiinflammatory properties. It has been introduced previously for intraoperative peritoneal lavage in treating peritonitis in adults. The aim of our study was to evaluate the effect of peritoneal taurolidine lavage on the clinical course and serological inflammation markers in children with perforated appendicitis and localised peritonitis. A series of 27 children presenting with appendicitis between January 1999 and July 2001 were included in the study after parental informed consent. All patients underwent open appendectomy. Taurolidine peritoneal lavage was applied in 15 randomly selected children (eight girls and seven boys; mean age 10 years and 10 months). Twelve children received saline peritoneal lavage and served as the control group (six girls and six boys; mean age 9 years and 7 months). Blood was taken preoperatively and on postoperative days 1, 3, 7, and 14. Full blood cell count, C-reactive protein, endotoxin, interleukin-1, interleukin-6, soluble interleukin-2 receptor, tumour necrosis factor α, and procalcitonin were investigated to evaluate the serological course of inflammation. Both groups initially presented with severe inflammation as evidenced clinically and serologically. The clinical postoperative course was uneventful in 13/15 patients in the treatment group and 10/12 patients in the control group. The remaining patients presented complications: intraperitoneal abscess or early postoperative bowel obstruction. With regard to the serological inflammatory parameters, no significant differences were found between the two groups except for the soluble interleukin-2-receptor on the 7th postoperative day. In conclusion, the expected reduction of endotoxin levels and inflammatory activity in the treatment group was not evident. A significant advantage of adjuvant peritoneal taurolidine lavage in the surgical therapy of children with localised peritonitis due to appendicitis could not be shown in our study.
Similar content being viewed by others
References
Bauhofer A, Stinner B, Kohlert F, Reckzeh B, Lorenz W, Celik I (2002) Granulocyte colony-stimulating factor but not peritoneal lavage increases survival rate after experimental abdominal contamination and infection. Br J Surg 89(11):1457–1464
Bedrosian I, Sofia RD, Wolff SM, Dinarello CA (1991) Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 3(6):568–575
Görtz G (1997) Lokale antiseptische und antiendotoxische Massnahmen bei intraabdominalen Infektionen. Langenbecks Arch Chir 382(Suppl 1):S37–S41
Konukoglu D, Iynem H, Ziylan E (1999) Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin. Pharmacol Res 39(3):247–251
Manocha S, Feinstein D, Kumar A, Kumar A (2002) Novel therapies for sepsis: antiendotoxin therapies. Expert Opin Investig Drugs 11(12):1795–1812
Reith HB (1997) Therapy of Peritonitis today. Surgical management and adjuvant therapy strategies. Langenbecks Arch Chir 382(4 Suppl 1):S14–S17
Rosman C, Westerveld GJ, van Oeveren W, Kooi K, Bleichrodt RP (1996) Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid an plasma in rats. Eur Surg Res 28(5):351–360
Rosman C, Westerveld GJ, Kooi K, Bleichrodt RP (1999) Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality. Eur J Surg 165(11):1072–1079
Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202
Staubach KH (1997) Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation. Langenbecks Arch Chir 382(4 Suppl 1):S26–S30
Willatts SM, Radford S, Leitermann M (1995) Effect of the antiendotoxic agent taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double blind trial. Crit Care Med 23(6):1033–1039
Woltmann A, Schult M, Schiedeck T, Markert U, Bruch HP (1999) Peritoneal lavage in standardized peritonitis models. Zentralbl Chir 124(3):195–198
Acknowledgements
This study was supported by the Interdisciplinary Centre of Clinical Research at the Leipzig University (IZKF), Grant Z 10.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schneider, A., Sack, U., Rothe, K. et al. Peritoneal taurolidine lavage in children with localised peritonitis due to appendicitis. Ped Surgery Int 21, 445–448 (2005). https://doi.org/10.1007/s00383-005-1428-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-005-1428-3